American Diabetes Association Symposium to Bring to Light the Impact of Suicide and Depression on Adolescents with Type 1 Diabetes

Suicide is a leading cause of death among young people ages 20 to 24 in the United States, and the risk is even higher in individuals with type 1 diabetes. In fact, up to 7% of deaths in individuals with type 1 diabetes are a result of suicide. However, current screening tools for depression and suicide often miss individuals at risk of suicide and the risk among the type 1 diabetes patient population is greatly underestimated.

The symposium will highlight the work of RESCUE and address solutions for two distinct uncertainties faced by health care providers in the management of people with type 1 diabetes at risk of suicide: how to identify those at risk and the best way to prevent and reduce that risk .

Discussion topics will include:

  • Depression, Suicidal Ideation, and Self-Harm among Adults with Diabetes—Unmet Needs and How to Address Them
  • Partnership Among RESCUE, Advocacy, and Industry to Address Suicide and Self-Harm in Diabetes
  • Educational Support Needs for Addressing Suicide and Self-Harm in Diabetes

“Suicide and self-harm are an all-too-common reality for young adults with type 1 diabetes, but it doesn’t have to be. With a multi-pronged approach to awareness, education, and identification, we have the opportunity to intervene on the link between suicide and diabetes,” said Professor Katharine Barnard Kelly, PhD., RESCUE Collaborative Community. “With this symposium, it is our hope that we can reach stakeholders with awareness and arm them with messages that can ultimately save a young person’s life if adopted in clinical practice and through mental health screenings.”

professor Katharine Barnard KellyPhD and the RESCUE team will present during the symposium, Suicide and Self-Injury—Unveiling and Addressing the Hidden Nightmare in Diabetes on Friday, June 3 from 4:15-6:15pm CT.

For more information, please contact the ADA Scientific Sessions media team onsite at the Ernest N. Morial Convention Center from June 3–7 by phone at 504-670-4902, or by email at [email protected].

About the ADA’s scientific sessions
the ADA’s 82nd Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention, and care, will be a hybrid event held June 3–7, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. Leading physicians, scientists, and health care professionals from around the world will unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. We are eager to get back to safely participating in person and networking with colleagues while hearing the latest scientific advances and groundbreaking research presentations. Learn more and register at and join the Scientific Sessions conversation on social media using #ADA2022.

About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For 81 years, the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. Through advocacy, program development, and education we aim to improve the quality of life for the over 133 million Americans living with diabetes or prediabetes. Diabetes has brought us together, what we do next will make us Connected for Life. To learn more or to get involved, visit us at or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), Twitter (@AmDiabetesAssn), and Instagram (@AmDiabetesAssn).

SOURCE American Diabetes Association


Related Posts